首页> 美国卫生研究院文献>Cancers >Lymphoepithelial Carcinoma of Larynx and Hypopharynx: A Rare Clinicopathological Entity
【2h】

Lymphoepithelial Carcinoma of Larynx and Hypopharynx: A Rare Clinicopathological Entity

机译:喉淋巴脑膜炎癌和低咽喉癌:罕见的临床病理实体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(1) Background: Lymphoepithelial carcinoma of the hypopharynx and larynx is a rare tumor with fewer than 50 cases in the published literature. We present a literature review to discuss the clinical findings, viral or genetic associations, diagnostic challenges, histopathological findings and therapeutic aspects of the disease. (2) Methods: A comprehensive literature review was performed through MEDLINE/PubMed from 1968 to 2018. We identified 21 studies comprising 46 patients. Data on all the clinicopathological features, diagnostic modalities, treatment options and viral or genetic etiology were extracted and analyzed using SPSS. (3) Results: The mean age of presentation was 64 years (range 40–82 years) and mostly involved males. The supraglottis and pyriform sinus were the most commonly involved sub-sites, with surgery as the preferred treatment modality. The presence of the Epstein–Barr virus possibly directs a viral etiology. The incidence of cervical and distant metastasis was 54% and 21%, respectively. The median survival time was 30 months. (4) Conclusions: Lymphoepithelial carcinoma of the hypopharynx is an aggressive tumor with a strong predilection for regional and distant metastasis. Surgery, in combination with adjuvant therapy, provides promising results. Immunohistochemistry helps in differentiating LEC from other pathologies.
机译:(1)背景:淋巴上皮癌的后咽癌和喉部癌是一种罕见的肿瘤,在出版文献中少于50例。我们提出了一个文献综述,讨论了临床发现,病毒或遗传关联,诊断挑战,组织病理学发现和疾病的治疗方面。 (2)方法:通过1968年至2018年通过Medline / Pubmed进行了全面的文献综述。我们确定了21项研究,包括46名患者。用SPSS提取和分析所有临床病理特征,诊断方式,治疗方案和病毒或遗传学病因的数据。 (3)结果:平均介绍年龄为64岁(范围40-82岁),主要涉及雄性。 Supraglottis和吡虫窦是最常见的子位点,手术是优选的治疗方式。 Epstein-Barr病毒的存在可能引导病毒病因。宫颈和远离转移的发病率分别为54%和21%。中位生存时间为30个月。 (4)结论:淋巴上皮癌的后咽癌是一种激进的肿瘤,具有强烈的区域和遥远的转移。手术与佐剂治疗组合,提供了有希望的结果。免疫组织化学有助于将LEC与其他病理学区分开来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号